Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Sep-Oct;89(5):I16-8.
doi: 10.1007/BF03404494.

Adherence to pharmacologic management of hypertension

R Feldman  1 , M Bacher, N Campbell, A Drover, A Chockalingam
Affiliations

Adherence to pharmacologic management of hypertension

R Feldman et al. Can J Public Health. 1998 Sep-Oct.

Abstract
in English, French

Adherence to pharmacologic therapy of hypertension is low (in the range of 50-70%) and has important implications both for blood pressure control and cardiovascular complications. Based on a review of the literature using the levels of evidence grading technique, determinants of adherence to the pharmacologic therapy of hypertension have been assessed. Additionally, interventions to improve compliance were evaluated. Patient-centred, health care provider-centred and drug-specific factors have all been shown to affect adherence rates. We conclude that the extent of adherence to pharmacologic therapy is modifiable. Measurable improvements in adherence can be obtained from simplified medication regimens and a combination of behaviour strategies, including the tailoring of pill-taking to patients' daily habits and rituals, the advocacy of self-monitoring of pills and blood pressure, and the institution of reward systems.

L’observance des pharmacothérapies pour le traitement de l’hypertension est faible (de l’ordre de 50 à 70 %) et a des implications importantes tant sur le contrôle de la tension artérielle que sur les complications cardiovasculaires. À partir d’un examen de la literature se servant des niveaux de la technique de graduation des preuves, on a évalué les determinants de l’observance des pharmacothérapies pour le traitement de l’hypertension. En outre, on a aussi évalué les interventions visant à améliorer l’observance. Les facteurs propres aux patients, aux soignants et aux médicaments ont tous indiqué qu’ils avaient une influence sur les taux d’observance. Nous en concluons que la portée de l’observance des pharmacothérapies est modifiable. Des améliorations mesurables de l’observance sont possibles grâce à des régimes médicamenteux simplifiés et à une combinaison de stratégies de comportement comprenant l’adaptation de la prise des médicaments aux habitudes et aux rituals quotidiens des patients, l’encouragement de l’autosurveillance de la tension artérielle et de la prise des médicaments, ainsi que l’établissement d’un système de récompenses.

PubMed Disclaimer

References

    1. Haynes RB. Improving patient compliance in the management of hypertension. In: Kaplan NM, Ram CV, editors. Individualized Therapy of Hypertension. New York: Marcel Dekker Inc.; 1995. pp. 257–73.
    1. Luscher TF, Vetter H, Siegenthaler W, Vetter W. Compliance in hypertension: facts and concepts. J Hypertension. 1985;3:3–9. - PubMed
    1. Haynes RB, Taylor W, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2:757–64. doi: 10.1161/01.HYP.2.6.757. - DOI - PubMed
    1. Logan AG, Achber C, Milne B, et al. Work-site treatment of hypertension by specially trained nurses. Lancet. 1979;11:1175–78. doi: 10.1016/S0140-6736(79)92397-3. - DOI - PubMed
    1. Morisky DE, Levine DM, Green LW, et al. Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health. 1963;73:153–62. doi: 10.2105/AJPH.73.2.153. - DOI - PMC - PubMed

Substances